83 related articles for article (PubMed ID: 9346327)
1. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327
[TBL] [Abstract][Full Text] [Related]
2. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
[TBL] [Abstract][Full Text] [Related]
3. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
[TBL] [Abstract][Full Text] [Related]
5. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo.
Vincent B; Dive V; Yiotakis A; Smadja C; Maldonado R; Vincent JP; Checler F
Br J Pharmacol; 1995 Jul; 115(6):1053-63. PubMed ID: 7582503
[TBL] [Abstract][Full Text] [Related]
6. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.
Barelli H; Fox-Threlkeld JE; Dive V; Daniel EE; Vincent JP; Checler F
Br J Pharmacol; 1994 May; 112(1):127-32. PubMed ID: 8032633
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and analgesic effects of N-[3-[(hydroxyamino) carbonyl]-1-oxo-2(R)-benzylpropyl]-L-isoleucyl-L-leucine, a new potent inhibitor of multiple neurotensin/neuromedin N degrading enzymes.
Doulut S; Dubuc I; Rodriguez M; Vecchini F; Fulcrand H; Barelli H; Checler F; Bourdel E; Aumelas A; Lallement JC
J Med Chem; 1993 May; 36(10):1369-79. PubMed ID: 8496905
[TBL] [Abstract][Full Text] [Related]
8. Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16.
Dauch P; Barelli H; Vincent JP; Checler F
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):421-6. PubMed ID: 1747117
[TBL] [Abstract][Full Text] [Related]
9. Interactions between NTS2 neurotensin and opioid receptors on two nociceptive responses assessed on the hot plate test in mice.
Bredeloux P; Costentin J; Dubuc I
Behav Brain Res; 2006 Dec; 175(2):399-407. PubMed ID: 17074405
[TBL] [Abstract][Full Text] [Related]
10. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice.
Noble F; Roques BP
FEBS Lett; 1997 Jan; 401(2-3):227-9. PubMed ID: 9013892
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of neurotensin receptors and of the neurotensin-degrading enzyme endopeptidase 24-16 in primary cultures of neurons.
Chabry J; Checler F; Vincent JP; Mazella J
J Neurosci; 1990 Dec; 10(12):3916-21. PubMed ID: 2176676
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of endopeptidase 24.16 by dipeptides.
Dauch P; Vincent JP; Checler F
Eur J Biochem; 1991 Dec; 202(2):269-76. PubMed ID: 1761032
[TBL] [Abstract][Full Text] [Related]
14. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices.
McDermott JR; Gibson AM; Turner JD
Biochem Biophys Res Commun; 1987 Jul; 146(1):154-8. PubMed ID: 2886123
[TBL] [Abstract][Full Text] [Related]
15. Rat kidney endopeptidase 24.16. Purification, physico-chemical characteristics and differential specificity towards opiates, tachykinins and neurotensin-related peptides.
Barelli H; Vincent JP; Checler F
Eur J Biochem; 1993 Jan; 211(1-2):79-90. PubMed ID: 8425555
[TBL] [Abstract][Full Text] [Related]
16. JMV 449: a pseudopeptide analogue of neurotensin-(8-13) with highly potent and long-lasting hypothermic and analgesic effects in the mouse.
Dubuc I; Costentin J; Doulut S; Rodriguez M; Martinez J; Kitabgi P
Eur J Pharmacol; 1992 Aug; 219(2):327-9. PubMed ID: 1425958
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive properties of inhibitors of endopeptidase 24.15.
Kest B; Orlowski M; Molineaux CJ; Bodnar RJ
Int J Neurosci; 1991; 56(1-4):141-9. PubMed ID: 1938129
[TBL] [Abstract][Full Text] [Related]
18. New hydroxamate inhibitors of neurotensin-degrading enzymes. Synthesis and enzyme active-site recognition.
Bourdel E; Doulut S; Jarretou G; Labbe-Jullie C; Fehrentz JA; Doumbia O; Kitabgi P; Martinez J
Int J Pept Protein Res; 1996 Aug; 48(2):148-55. PubMed ID: 8872532
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of a neurotensin-degrading endopeptidase from pig brain.
Millican PE; Kenny AJ; Turner AJ
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):583-91. PubMed ID: 1905921
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin.
Vincent B; Vincent JP; Checler F
Brain Res; 1996 Feb; 709(1):51-8. PubMed ID: 8869556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
